Rhm suppression of inflammatory markers such as NFκB, a promotor of major inflammatory cascade in NASH [72], was reported before [22], but in this study it was reported in NASH model and HCC. The gene discussed is NFKB1; the disease is metabolic dysfunction-associated steatohepatitis.